glp-1 nmda Frontiers Glucagon-Like Peptide-1 Receptors in the

BPC-157 , , ( )

GLP-1 for sleep apnea, alcohol use and cancer risk GLP-1s may address conditions well beyond metabolic diseases: Obstructive sleep apnea: Emerging data suggest GLP-1s improve apnea symptoms. Alcohol use disorder: Patients using liraglutide or semaglutide reduced alcohol consumption by nearly two-thirds. Obesity-related cancers: An observational study of 6,000 adults found that GLP-1 receptor agonists halved the risk of obesity-related cancers compared with usual care

If your instructions include cleaning the skin with alcohol, let the alcohol dry fully before injecting, since wet alcohol can sting too

doi: 10.1371/journal.pone.0011624